Sign inGet started

Pascale Adam

Insider CIK 1613377 · HEB Chief Accounting Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
HEB HEMISPHERX BIOPHARMA INC C Conversion2019-05-082019-06-1735,000— $0147,148SEC↗
HEB HEMISPHERX BIOPHARMA INC C Conversion2019-03-182019-06-1750,000— $0112,148SEC↗
HEB HEMISPHERX BIOPHARMA INC X Exercise deriv2019-02-272019-03-1210$1000.00 $10.0K0SEC↗
HEB HEMISPHERX BIOPHARMA INC X Exercise2019-02-272019-03-1210— $010SEC↗
HEB HEMISPHERX BIOPHARMA INC X Exercise2019-02-272019-03-1250,000— $050,000SEC↗
HEB HEMISPHERX BIOPHARMA INC A Award deriv2019-01-282019-01-30142,046— $0142,046SEC↗
HEB HEMISPHERX BIOPHARMA INC A Award2018-11-272018-11-292,500— $062,148SEC↗
HEB HEMISPHERX BIOPHARMA INC A Award deriv2018-11-142018-11-161,000— $01,000SEC↗
HEB HEMISPHERX BIOPHARMA INC A Award deriv2018-10-172018-10-1994,697— $094,697SEC↗
HEB HEMISPHERX BIOPHARMA INC P Buy2018-07-232018-07-2332,259$0.31 $10.0K59,648SEC↗
HEB HEMISPHERX BIOPHARMA INC A Award deriv2018-07-182018-07-1953,763— $053,763SEC↗
HEB HEMISPHERX BIOPHARMA INC A Award deriv2018-05-162018-05-1883,334— $083,334SEC↗
HEB HEMISPHERX BIOPHARMA INC A Award deriv2018-04-122018-04-1975,000— $075,000SEC↗
HEB HEMISPHERX BIOPHARMA INC A Award deriv2018-02-132018-03-01123,874— $0123,874SEC↗
HEB HEMISPHERX BIOPHARMA INC A Award deriv2017-08-312017-09-018,155$0.26 $2.1K8,155SEC↗
HEB HEMISPHERX BIOPHARMA INC A Award deriv2017-08-152017-08-167,112$0.29 $2.1K7,112SEC↗
HEB HEMISPHERX BIOPHARMA INC A Award deriv2017-07-312017-08-016,929$0.30 $2.1K6,929SEC↗
HEB HEMISPHERX BIOPHARMA INC A Award deriv2017-07-152017-07-176,042$0.34 $2.1K6,042SEC↗
HEB HEMISPHERX BIOPHARMA INC A Award deriv2017-06-302017-07-054,738$0.44 $2.1K4,738SEC↗
HEB HEMISPHERX BIOPHARMA INC A Award deriv2017-06-152017-06-194,765$0.44 $2.1K4,765SEC↗
HEB HEMISPHERX BIOPHARMA INC A Award deriv2017-06-152017-06-294,738$0.44 $2.1K4,738SEC↗
HEB HEMISPHERX BIOPHARMA INC P Buy2017-05-022017-05-0215,873$0.63 $10.0K27,389SEC↗
HEB HEMISPHERX BIOPHARMA INC P Buy2017-02-162017-02-216,981$0.46 $3.2K11,516SEC↗
HEB HEMISPHERX BIOPHARMA INC A Award deriv2016-07-292016-07-2913,077$0.13 $1.7K13,077SEC↗
HEB HEMISPHERX BIOPHARMA INC A Award deriv2016-07-152016-07-1914,167$0.12 $1.7K14,167SEC↗
HEB HEMISPHERX BIOPHARMA INC A Award deriv2016-06-302016-06-3014,167$0.12 $1.7K14,167SEC↗
HEB HEMISPHERX BIOPHARMA INC A Award deriv2016-06-212016-06-23150,000— $0150,000SEC↗
HEB HEMISPHERX BIOPHARMA INC A Award deriv2016-06-152016-06-1615,455$0.11 $1.7K15,455SEC↗
HEB HEMISPHERX BIOPHARMA INC A Award deriv2016-05-312016-06-0114,167$0.12 $1.7K14,167SEC↗
HEB HEMISPHERX BIOPHARMA INC A Award deriv2016-05-152016-05-1615,455$0.11 $1.7K15,455SEC↗
HEB HEMISPHERX BIOPHARMA INC A Award deriv2016-04-302016-05-0312,143$0.14 $1.7K12,143SEC↗
HEB HEMISPHERX BIOPHARMA INC A Award deriv2016-04-152016-04-1912,143$0.14 $1.7K12,143SEC↗
HEB HEMISPHERX BIOPHARMA INC A Award deriv2016-03-312016-04-0613,077$0.13 $1.7K13,077SEC↗
HEB HEMISPHERX BIOPHARMA INC A Award deriv2016-03-152016-04-0610,625$0.16 $1.7K10,625SEC↗
HEB HEMISPHERX BIOPHARMA INC A Award deriv2016-02-292016-04-0610,500$0.15 $1.6K10,500SEC↗
HEB HEMISPHERX BIOPHARMA INC A Award deriv2016-02-152016-04-0610,694$0.12 $1.3K10,694SEC↗
HEB HEMISPHERX BIOPHARMA INC J Other deriv2014-12-082014-12-097,176— $0127,648SEC↗
HEB HEMISPHERX BIOPHARMA INC J Other deriv2014-07-082014-07-1150,000— $0127,648SEC↗